Robert Schuster, PhD, is a Protein Characterization Scientist at GSK, specializing in antibody conjugation and mass spectrometry. With expertise in antibody-drug and antibody-oligo conjugation R&D, Robert has held senior roles at Abzena and Novatia, LLC, where they developed methods for small molecule-antibody conjugation and characterized biomolecules to support client drug pipelines. Robert earned a Ph.D. in Medicinal Chemistry from Purdue University and has experience in advanced mass spectrometry from their research at institutions like the University of Washington and Tufts University.
This person is not in any teams
This person is not in any offices